January 31, 2023
Julia Moore Vogel, PhD
and
Sanjay Mathew, MD - ADAA President-Elect and Chief Medical Officer
and
Diversity matters when it comes to mental health. This free fireside chat with Dr. Julia Moore Vogel will discuss the All of Us Research Program and how it's addressing mental health disparities.
July 11, 2022
Alex Bettis, PhD
and
Kirsty Clark, PhD, MPH
and
Autumn Kujawa, PhD
and
Jessica M. Schwartzman, PhD
and
October 27, 2022
Robin Carhart-Harris, PhD
and
Greg Fonzo, PhD
and
Stephen Ross, MD
and
Rachel Yehuda, PhD
and
The 2022 Fall Forum brings together several leading experts to provide their clinical and research perspectives on the psychedelic medicine field as it pertains to depression, anxiety, and PTSD.
April 21, 2022
David Mischoulon, MD, PhD
and
The presentation will review selected nutraceutical and herbal remedies that are used for treating depression and anxiety.
February 15, 2022
Sameer Sheth, MD, PhD
and
This webinar provides an overview of the history of DBS for TRD, focusing on the last 10 years of effort. During this time, there have been a number of open label and randomized controlled trials that have shed light on this therapy. The webinar also discusses current trials in this field.
January 27, 2022
Greg Fonzo, PhD
and
There is a recent and growing resurgence of interest in the potential for psychedelic compounds to be utilized as treatments for mood and anxiety disorders. Learn about a broad overview of the history, current clinical practice, and potential therapeutic mechanisms underlying psilocybin-assisted psychotherapy.
October 21, 2021
Alan F. Schatzberg, MD
and
Gabriela Livas Stein, PhD
and
Namkee Choi, PhD
and
Shawn Jones, PhD, MHS
and
Gabrielle Liverant, PhD
and
David Mischoulon, MD, PhD
and
Barbara Kamholz, PhD, ABPP Senior Advisor, Professional Education
and
ADAA's annual Fall Forum - eligible for 2-3 CE/CME credits brought together a panel of renowned experts in an engaging and interactive presentation.
December 10, 2020
R. Trent Codd, III, EdS
and
May 28, 2020
Medical Marijuana Laws & Evidence for Harmful/Beneficial Effects in Depression and Anxiety Disorders
Rajiv Radhakrishnan MBBS, MD
and
Kevin A. Sabet, PhD
and
April 20, 2020
Sheila Rauch, PhD, ABPP
and
The current COVID-19 pandemic is unprecedented in reach around the world and the extended nature of this invisible threat. All are impacted whether it is direct impact on health or employment or indirect impact through availability of services and loved ones.
